Enteral Feeding of Premature Babies and Olive Oil Supplementation
Trial Parameters
Brief Summary
It is a two-arm prospective interventional study. 40 babies in both groups will be enrolment in the study. In the intervention group, babies will take 1 ml/kg/day of the study product (ULTRA PREMIUM) after full enteral feeding. Supplementation will continue until discharge or the 36th week. Blood samples will be taken for serum Total antioxidant capacity and Malondialdehyde levels before the intervention and on the 14th day of the control group. At the end of the study, serum will be taken again for control values. Daily lipid intake amounts will be recorded through breast milk analysis. Lipid profile will be monitored weekly The growth parameters of babies will be monitored daily It will be evaluated at the end of the study in terms of ROP, BPD, and NEC. At the end of the study, the data of babies in both groups will be compared.
Eligibility Criteria
Inclusion Criteria: * Premature babies born at 32 weeks or less * Babies who tolerate full enteral feeding at the before end of the second week * Babies given consent by their parents - Exclusion Criteria: * Having a congenital or genetic anomaly